Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules solely from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company provides specific proprietary software products, such as GastroPlus, a physiologically-based simulation tool that predicts the absorption, pharmacokinetics, pharmacodynamics, and drug-drug interactions for compounds administered through intravenous, oral, ocular, or pulmonary routes; ADMET Predictor, an ADME-Tox property prediction, and model building application; MedChem Studio, a multi-purpose cheminformatics platform used for advanced data mining and de novo molecule design; DDDPlus, a simulation program for formulation scientists that predicts the in vitro disintegration and dissolution of solid dosage forms under different experimental conditions;  MedChem Designer, a free chemical sketching product that combines innovative molecule drawing features with fast and accurate ADMET property predictions from ADMET Predictor.